AstraZeneca AB et al v. Mylan Laboratories Limited et al
| AstraZeneca AB, Aktiebolaget Hassle, Astrazeneca LP, KBI Inc. and KBI-E Inc. |
| Mylan Laboratories Limited, Mylan Laboratories Inc., Mylan Inc., Matrix Laboratories Limited and Matrix Laboratories Inc. |
| 1:2012cv00300 |
| March 12, 2012 |
| US District Court for the District of Delaware |
| Wilmington Office |
| XX Outside US |
| Mary Pat Thynge |
| Patent |
| 35 U.S.C. ยง 271 |
| None |
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
